We are currently in the process of upgrading the members area of the website, you will be unable to access membership specific files while the upgrade is in progress. To manage your membership please access my.bsgm.org.uk.

Sub-Committees

  • Academic sub-committee

    This sub-committee was established by Council in 2008.

    Constitution

    The committee will be chaired by the Academic Vice-President of the Clinical Genetics Society.

    The members of the committee will be the Academic Programme Organisers (Walport), SAC Chair or representative, UKCRN Clinical Genetics Specialty Interest Group Chair or representative, Representative from Scotland, a representative of the Academic Clinical Fellows, a representative of the Academic Clinical Lecturers and an NHS Clinical Genetics representative. One member may serve more than one of the above functions.

    The committee shall meet at least annually.

     

    The committee will be deemed to be quorate if the chair and six members are present.

     

    The Committee shall report to the Clinical Genetics Society Council

    Terms of Reference and Remit

    i) To monitor the management of academic posts and the progression of academic clinical fellows (Walport), and clinical lecturers and others in research training posts.

    ii) To promote  Academic Clinical Genetics with those entering the medical profession and with Professional Bodies.

    iii) To liaise with SAC regarding academic issues relating to training.

    iv) To liaise with the committee working on revalidation regarding revalidation of clinical academics.

    v) To liaise with UKCRN Genetics Specialty Interest Group  regarding research networks.

      Membership of the sub-committee:

    • Judith Goodship, Academic Vice-President
  • Clinical Governance sub-committee

    Chair: Dr Sarah Smithson

    Remit of the Sub-Committee
    The Clinical Governance Subcommittee exists to promote the development of quality standards for Clinical Genetics Practice in the UK, and was set up by the Clinical Genetics Society in the late 1990s. The remit is:

    • Setting standards for clinical genetic practice
    • Developing a framework for the delivery of standards
    • Developing a framework for local monitoring of standards
       

    Clinical Standards Document (2005)
    To this end, we have developed a  Clinical Standards document [pdf]  for clinical genetics services, which helps define the general service qualities which Clinical Genetics Units should aim to deliver.

    Guidance in Clinical Genetics Practice
    Some clinical guidelines exist for genetic disorders, such as Tuberous Sclerosis, Myotonic Dystrophy, Marfan Syndrome and some Familial Cancers. Many of these guidelines are currently under review. We have lines of communication with the Royal College of Physicians of London and other interdisciplinary groups for discussion of clinical guidelines.

    We have looked at several specific areas of clinical genetic practice, and have produced guidance documents for these. These include:

    Patient Information Leaflets
    We are also developing generic patient information leaflets for generic processes in clinical genetics, such as a preclinic information leaflet, genetic testing, genetic testing in children, genetics and prenatal testing and cancer genetics, and we hope to publish templates for these here soon.

    Developing new guidelines or recommended management plans
    We wish to provide a forum to promote guidelines for clinical genetic practice and would be keen to hear from centres who have developed their own guidelines or recommended management plans for specific disorders. We hope this might stimulate discussion and promote the development of more widely accepted standards of clinical practice in these disorders. Any new proposal should involve at least one consultant and at least one clinical genetics SpR as a nucleus for development. Multidisciplinary involvement is more likely to result in wide acceptance of any document produced.

    Suggested topics include NF1, NF2, MEN 1, MEN2, FMTC, Li-Fraumeni, pre-lingual deafness and genetic testing in diabetes, but if there is another disorder which you would like to provide guidance for, we would like to hear from you! Please contact the chairman if you would like the subcommittee to consider publicising your guideline or management plan on this website. 

    If there are any other issues which you think the committee should address, or comments about the documents or other information on this website, please don't hesitate to contact us, as we exist to help you provide a better clinical genetics service for patients, and would welcome feedback

  • Nominations committee

    This subcommittee was established by Council at its meeting in November 2006. Its terms of reference are to develop and review a specification for the Carter Lecturer and to propose suggested names to Council approximately 18 months in advance of the Lecture

    Membership:

    • Chair: President of CGS (or Vice President if that person will be the President at the time of the Carter Lecture) 
    • BSHG conference organiser
    • Cancer genetic group representative
    • Senior member of the Society invited by the chairperson
    • Other senior members of the society may be invited to join the committee. This will include the CGS conference organiser and others as needed to achieve a balance of representation between the different Sub-Specialties of Clinical Genetics.

    Carter lecturer:

    The following specification was agreed by the Committee as its first meeting in February 2007:   

    The person invited to deliver the Carter Lecture must have made a world class contribution to the practice of Medical Genetics either through basic science, translational research or patient contact and to have upheld the ethical principles of Medical Genetics practice.  It was agreed that some objective criteria should be applied that would provide an external marker for the scientific excellence of the speaker.  The criteria for UK lecturers could be more easily designated than overseas colleagues and so the following specification was made:  the lecturer should normally be an FRS or FMedSci or equivalent. 

    It was agreed that we recommend to the CGS Council that the above recommendations are kept under review and specifically: 

    The terms of reference for the Carter lecturer are reviewed as a standing item on the agenda of the nominations committee whenever the committee meets to propose a future lecturer.

  • Consultants Revalidation sub-committee

    This sub-committee was established by Council at its meeting in November 2006.

    Remit of the sub-committee:

    To provide the specialty with information and guidance about the process and requirements for re-licensing and re-certification To lead re-certification for the speciality in conjunction with the Royal Colleges with regard to setting standards, identifying specific areas for assessment and suggesting methods of assessment.

    Membership of the sub-committee:

    • Alan Fryer, Chairman
    • Helen Kingston, General Secretary of CGS
    • John Dean, chairman of Clinical Governance committee (and representing Scotland)
    • Gareth Evans, representative of the Cancer Genetics Group
    • Daniela Pilz, general member (and representing Wales)
    • Richard Trembath, representative of academic clinical geneticists
    • A representative of the Clinical Genetics SAC of the Royal College of Physicians
    • Alex Magee (representative from Northern Ireland Genetic Service)
    • A representative of the National Genetic Education Centre
    • Representation from the Royal College of Physicians Clinical Standards Project Group
    • Chris Friend (a patient representative nominated by the Genetics Interest Group)

    First meeting was held at the RCP on 1st March 2007:

    The white paper "Trust, Assurance and Safety - The Regulation of Health Professional in the 21st Century" Feb 2007 was the basis of the discussion at the first meeting.
    The committee would value the views of any members on the issues raised in this report and specifically on the standards that may be set, specific areas for assessment and suggestions for methods of assessment. 

  • Prenatal Genetics sub-group

    Chair: Dr Peter Turnpenny

    Terms of reference

    • i) To review the existing guidelines and statements from national bodies that address the working relationships and clinical liaison between fetal medicine and clinical genetics
    • ii) To review current models of care between fetal medicine and clinical genetics; 
    • iii) In the light of the findings from these reviews to appropriately work with the Royal College of Obstetricians and Gynaecologists, and Midwives, to produce a joint document whose aim would be to: 
      • a) describe best practice
      • b) propose good models of care, with resource implications
      • c) propose models of education and training appropriate for trainees in fetal medicine, clinical genetics and midwives.